e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Infection in the immunocompromised host: infrequent aetiologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection
N. Asai, Y. Ohkuni, R. Matsunuma, K. Nakashima, H. Makino, T. Nakashita, Y. Otsuka, S. Motojima, N. Kaneko (Kamogawa, Japan)
Source:
Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Session:
Infection in the immunocompromised host: infrequent aetiologies
Session type:
Thematic Poster Session
Number:
2531
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Asai, Y. Ohkuni, R. Matsunuma, K. Nakashima, H. Makino, T. Nakashita, Y. Otsuka, S. Motojima, N. Kaneko (Kamogawa, Japan). Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection. Eur Respir J 2011; 38: Suppl. 55, 2531
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients
Source: Eur Respir J 2001; 17: 87-93
Year: 2001
Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation
Source: Eur Respir J 2010; 35: 927-929
Year: 2010
Radiological features of pneumocystis pneumonia (PCP) without HIV
Source: Annual Congress 2011 - Imaging in oncology and infectious diseases
Year: 2011
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with
Pneumocystis
pneumonia
Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019
Year: 2020
Early recurrence of
pneumocystis jiroveci
pneumonia (PCP) in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Virological diagnosis in community-acquired pneumonia in immunocompromised patients
Source: Eur Respir J 2008; 31: 618-624
Year: 2008
Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1213
Year: 2014
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1214
Year: 2014
Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept